Description

Molecular targets of resveratrol in MASLD are mapped, showing its reported effects on AMPK activation, SIRT1 expression, and NF-kB-mediated inflammatory pathways.

Figure 2

Diagram

Source Paper

Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?

International journal of molecular sciences (2024)

PMID: 38612556

DOI: 10.3390/ijms25073746

Cite This Figure

![Figure 2: Molecular targets of resveratrol in MASLD are mapped, showing its reported effects on AMPK activation, SIRT1 expression, and NF-kB-mediated inflammatory pathways.]()

> Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." *International journal of molecular sciences*, 2024. PMID: [38612556](https://pubmed.ncbi.nlm.nih.gov/38612556/)

<figure>
  <img src="" alt="Molecular targets of resveratrol in MASLD are mapped, showing its reported effects on AMPK activation, SIRT1 expression, and NF-kB-mediated inflammatory pathways." />
  <figcaption>Figure 2. Molecular targets of resveratrol in MASLD are mapped, showing its reported effects on AMPK activation, SIRT1 expression, and NF-kB-mediated inflammatory pathways.<br>  Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38612556/">38612556</a></figcaption>
</figure>

Preuves associées

Resveratrol pour Chronic Inflammation

Note C · 5 études